Cargando…
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
BACKGROUND: Plasma triglyceride (TG) levels are a significant risk factor for cardiovascular disease (CVD). The APOA5 gene is one of the crucial factors in plasma TG metabolism regulation. The rs662799 polymorphism in the APOA5 gene has been reported to be associated with cardiovascular disease. The...
Autores principales: | Jacob, Jerry, Boczkowska, Sylwia, Zaluska, Wojciech, Buraczynska, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450442/ https://www.ncbi.nlm.nih.gov/pubmed/36071387 http://dx.doi.org/10.1186/s12882-022-02925-1 |
Ejemplares similares
-
MMP9 Gene Polymorphism (rs3918242) Increases the Risk of Cardiovascular Disease in Type 2 Diabetes Patients
por: Buraczynska, Monika, et al.
Publicado: (2023) -
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients
por: Buraczynska, Monika, et al.
Publicado: (2021) -
Transcription factor 7-like 2 (TCF7L2) gene polymorphism and clinical phenotype in end-stage renal disease patients
por: Buraczynska, Monika, et al.
Publicado: (2014) -
Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients
por: Ouatou, Sanaa, et al.
Publicado: (2014) -
The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women
por: Wang, Yanmei, et al.
Publicado: (2016)